相似文献
1
(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.
Am J Nucl Med Mol Imaging. 2011;1(1):63-4. Epub 2011 Jul 30.
2
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
J Nucl Med. 2004 Jan;45(1):17-21.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
The Utility of F-FDG PET/CT for Monitoring Response and Predicting Prognosis after Glucocorticoids Therapy for Sarcoidosis.
Biomed Res Int. 2018 Mar 1;2018:1823710. doi: 10.1155/2018/1823710. eCollection 2018.
5
¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
Eur J Nucl Med Mol Imaging. 2016 May;43(5):983-993. doi: 10.1007/s00259-015-3295-z. Epub 2016 Jan 13.
6
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Oncologist. 2016 Aug;21(8):931-9. doi: 10.1634/theoncologist.2015-0353. Epub 2016 Jul 8.
7
Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Nucl Med Commun. 2014 Feb;35(2):123-34. doi: 10.1097/MNM.0000000000000022.
8
¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Nucl Med Commun. 2012 Oct;33(10):1089-95. doi: 10.1097/MNM.0b013e328356741f.
9
Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):85-94. doi: 10.1007/s00259-017-3811-4. Epub 2017 Aug 22.
引用本文的文献
1
A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling.
Am J Transl Res. 2021 Oct 15;13(10):11439-11449. eCollection 2021.
2
A Review on Green Synthesis, Biomedical Applications, and Toxicity Studies of ZnO NPs.
Bioinorg Chem Appl. 2018 Aug 1;2018:3569758. doi: 10.1155/2018/3569758. eCollection 2018.
3
Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery.
Curr Pharm Biotechnol. 2013;14(8):733-42. doi: 10.2174/1389201014666131226113300.
4
Positron emission tomography imaging of atherosclerosis.
Theranostics. 2013 Nov 2;3(11):894-902. doi: 10.7150/thno.5506.
5
Antibody-based imaging of HER-2: moving into the clinic.
Curr Mol Med. 2013 Dec;13(10):1523-37. doi: 10.2174/1566524013666131111120951.
6
Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.
Curr Mol Med. 2013 Dec;13(10):1538-48. doi: 10.2174/1566524013666131111121325.
7
Quantum dot-based nanoprobes for in vivo targeted imaging.
Curr Mol Med. 2013 Dec;13(10):1549-67. doi: 10.2174/1566524013666131111121733.
8
Biomedical applications of zinc oxide nanomaterials.
Curr Mol Med. 2013 Dec;13(10):1633-45. doi: 10.2174/1566524013666131111130058.
9
Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.
Small. 2014 Feb 26;10(4):631-45. doi: 10.1002/smll.201301174. Epub 2013 Sep 19.
10
Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Angiogenesis. 2013 Jul;16(3):663-74. doi: 10.1007/s10456-013-9344-y. Epub 2013 Mar 8.
本文引用的文献
1
How to study optimal timing of PET/CT for monitoring of cancer treatment.
Am J Nucl Med Mol Imaging. 2011;1(1):54-62. Epub 2011 Jul 20.
2
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.
3
Imaging in the era of molecular oncology.
Nature. 2008 Apr 3;452(7187):580-9. doi: 10.1038/nature06917.
4
Molecular imaging in living subjects: seeing fundamental biological processes in a new light.
Genes Dev. 2003 Mar 1;17(5):545-80. doi: 10.1101/gad.1047403.
5
A tabulated summary of the FDG PET literature.
J Nucl Med. 2001 May;42(5 Suppl):1S-93S.
6
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205.
Zotero 插件